Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,315 | 35,420 | 46,134 | 52,553 | 53,821 |
| Receivables | 95,942 | 68,324 | 63,745 | 55,284 | 58,022 |
| Other current assets | 525,705 | 30,063 | 19,959 | 21,158 | 18,150 |
| TOTAL | $668,487 | $138,065 | $135,153 | $131,150 | $144,799 |
| Non-Current Assets | |||||
| PPE Net | 1,816,794 | 2,005,299 | 1,807,560 | 1,748,885 | 1,565,722 |
| Investments And Advances | 473,792 | 246,450 | 80,582 | 82,210 | 76,814 |
| Intangibles | 21,527 | 23,517 | 25,485 | 4,128 | 273 |
| Other Non-Current Assets | 32,017 | 14,797 | 7,154 | 7,212 | 8,232 |
| TOTAL | $2,344,130 | $2,290,063 | $1,920,781 | $1,842,435 | $1,651,041 |
| Total Assets | $3,012,617 | $2,428,128 | $2,055,934 | $1,973,585 | $1,795,840 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 311,381 | 132,049 | 95,527 | 169,249 | 203,199 |
| Accounts payable and accrued liabilities | 81,510 | 102,091 | 46,088 | 28,664 | 28,779 |
| Accrued Expenses | 25,069 | 15,706 | 11,778 | 4,813 | 9,029 |
| TOTAL | $425,533 | $257,657 | $164,006 | $214,716 | $249,194 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,847,633 | 1,570,773 | 1,380,499 | 1,250,560 | 1,058,754 |
| Deferred Revenues | 7,573 | 7,811 | 10,613 | 11,990 | 7,172 |
| Other Non-Current Liabilities | 0 | 0 | 2,084 | -134 | -111 |
| TOTAL | $1,885,952 | $1,606,626 | $1,434,424 | $1,298,764 | $1,103,741 |
| Total Liabilities | $2,311,485 | $1,864,283 | $1,598,430 | $1,513,480 | $1,352,935 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,712 | 20,491 | 19,057 | 19,922 | 20,788 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 471,112 | 397,640 | 324,576 | 318,579 | 292,897 |
| Other shareholders' equity | 97,352 | -6,122 | -8,132 | -6,999 | -4,888 |
| TOTAL | $701,132 | $563,845 | $457,504 | $460,105 | $442,905 |
| Total Liabilities And Equity | $3,012,617 | $2,428,128 | $2,055,934 | $1,973,585 | $1,795,840 |